Nature CommunicationsCancer BiologyPeer-reviewed journal article
Single-Cell multiomics reveals ENL mutation perturbs kidney developmental trajectory by rewiring gene regulatory landscape
Lele SongiD, Qinglan LiiD, Lingbo Xia, Arushi SahayiD, Qi QiuiD, Y. LiiD, Haitao LiiD, Kotaro SasakiiD, Katalin SusztákiD, Hao Wu, Liling WaniD
Abstract
Cell differentiation during organogenesis relies on precise epigenetic and transcriptional control. Disruptions to this regulation can result in developmental abnormalities and malignancies, yet the underlying mechanisms are not well understood. Wilms tumors, a type of embryonal tumor closely linked to disrupted organogenesis, harbor mutations in epigenetic regulators in 30-50% of cases. However, the role of these regulators in kidney development and pathogenesis remains unexplored. By integrating mouse modeling, histological characterizations, and single-cell transcriptomics and chromatin accessibility profiling, we show that a Wilms tumor-associated mutation in the chromatin reader protein ENL disrupts kidney development trajectory by rewiring the gene regulatory landscape. Specifically, the mutant ENL promotes the commitment of nephron progenitors while simultaneously restricting their differentiation by dysregulating key transcription factor regulons, particularly the HOX clusters. It also induces the emergence of abnormal progenitor cells that lose their chromatin identity associated with kidney specification. Furthermore, the mutant ENL might modulate stroma-nephron interactions via paracrine Wnt signaling. These multifaceted effects caused by the mutation result in severe developmental defects in the kidney and early postnatal mortality in mice. Notably, transient inhibition of the histone acetylation binding activity of mutant ENL with a small molecule displaces transcriptional condensates formed by mutant ENL from target genes, abolishes its gene activation function, and restores developmental defects in mice. This work provides new insights into how mutations in epigenetic regulators can alter the gene regulatory landscape to disrupt kidney developmental programs at single-cell resolution in vivo. It also offers a proof-of-concept for the use of epigenetics-targeted agents to rectify developmental defects.
- organism: mouse
- assay: scRNA-seq
- assay: ATAC-seq
- research focus: development & morphogenesis
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
- Citations
- 8
- FWCI
- 1.41
- Field percentile
- top 16%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- WILMS TUMORIGENESIS IN HUMAN KIDNEY ORGANOIDS
V. Waehle, R. Ungricht, … J. Betschinger·bioRxiv·Feb 2, 2021
- Lysine-specific demethylase 1a is obligatory for gene regulation during kidney development
Savithri Balasubramanian Kota, Satya Keerthi Kota·bioRxiv·Feb 25, 2025
- The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor
D. Legge, L. Ling, … K. W. Brown·bioRxiv·Nov 2, 2020
- Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early stem cell origin
B. Royer-Pokora, W. Wruck, M. Beier·bioRxiv·Jun 10, 2022
- Identification of a core transcriptional program driving the human renalmesenchymal-to-epithelial transition
John-Poul Ng-Blichfeldt, Benjamin J. Stewart, … Katja Röper·Developmental CellPeer-reviewed·Feb 9, 2024
- Tumour suppressor WT1 regulates the let-7-Igf1r axis in kidney mesenchyme
R. Bharathavikru, J. Slight, … N. Hastie·bioRxiv·Oct 30, 2019